These results suggest that IL‐38 suppressed the accumulation of M1 macrophages and reduced MMP‐9 and MMP‐2 expression in the abdominal aortic wall during AAA development, indicating that IL‐38 treatment may be able to reduce AAA development. The gene discussed is IL1F10; the disease is triple-A syndrome.